Search the Newsreel

Sale of 12,712 shares planned in CLOV (Nasdaq: CLOV) notice

An affiliate of Clover Health Investments (Nasdaq: CLOV) plans to sell 12,712 Class A common shares, valued at $59,492.16, through Morgan Stanley Smith Barney LLC around July 15, 2026. These shares originated from restricted stock units granted as compensation. The filing also notes previous …

CLOV (Nasdaq: CLOV) plans Rule 144 sale of 60765 shares

Clover Health Investments, Corp. (Nasdaq: CLOV) has filed a Form 144 notice for the planned sale of 60,765 shares of Class A Common Stock. These shares originate from Restricted Stock Units granted as compensation and are scheduled to be sold on Nasdaq via Morgan …

CLOV (CLOV) plans sale of 23,463 Class A common shares

Clover Health Investments, Corp. (CLOV) has filed a Form 144 disclosing a planned sale of 23,463 shares of Class A Common Stock with an aggregate market value of $109,806.84 through Morgan Stanley Smith Barney LLC on July 15, 2026. These shares originated from restricted …

Grup Kresna (KREN) Minta Restu Buyback Saham 10 Persen

Berburu Investor Strategis, Quantum Investama (KREN) Fokus Garap Teknologi, dan Digital

Technical Analysis of Clover Biopharmaceuticals Ltd. (HKEX:2197)